Autori: Doina Popov
Editorial: Biochem. Biophys. Res. Commun. , 410, p.377-381, 2011.
Resistance to the hormones insulin and leptin are hallmarks in common for type 2 diabetes mellitus and obesity. Both conditions are associated with increased activity and expression of protein tyrosine phosphatase (PTP)1B. Therefore, inhibition of PTP1B activity or down-regulation of its expression should ameliorate insulin and leptin resistance, and may hold therapeutic utility in type 2 diabetes mellitus and
obesity control. This background has motivated the fervent search for PTP1B inhibitors, carried out in the recent years.
The purpose of this review is to provide the most recent advances in understanding the structural details of PTP1B molecule relevant to the interactions with inhibitors, and the progress towards compounds with enhanced membrane permeability, affinity, specificity, and potency on intracellular PTP1B; several inhibitors of benefit in type 2 diabetes mellitus and obesity control are presented and discussed.
Cuvinte cheie: PTP1B, Type 2 diabetes mellitus, obesity